InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001104659-22-035157 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-17 2022-03-15 AMPH PETERS WILLIAM J CFO, EVP, Treas A - Grant $0.00 +22.0K 120.1K +22% $0
D 2022-03-17 2022-03-15 AMPH PETERS WILLIAM J CFO, EVP, Treas S - Sale $34.46 -7,900 98.1K -7% -$272.2K
D 2022-03-17 2022-03-15 AMPH PETERS WILLIAM J CFO, EVP, Treas F - Tax $34.74 -5,989 114.1K -5% -$208.1K
D 2022-03-17 2022-03-15 AMPH PETERS WILLIAM J CFO, EVP, Treas A - Grant $0.00 +50.7K 50.7K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-15 A A 21,991 $0.00 120,133 D — — (F3) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2023.
2 Common Common Stock 2022-03-15 S D 7,900 $34.46 98,142 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2022-03-15 F D 5,989 $34.74 114,144 D — — (F4) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.
4 Derivative Employee Stock Option (right to buy) 2022-03-15 A A 50,743 $0.00 50,743 D $34.74 · — to 2032-03-15 50,743 Common Stock (F5) The shares subject to the option vest in four equal annual installments beginning on March 15, 2023.